BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

J. David Enloe, Jr. Appointed As President And Chief Executive Officer of Ajinomoto Althea, Inc.


1/6/2014 6:41:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

San Diego, California, January 7, 2014 — Executive search firm SANFORD ROSE ASSOCIATES® – TOFT GROUP, focusing exclusively on assignments for Life Sciences and Healthcare companies, is proud to announce another successful placement. Mr. J. David Enloe, Jr., CPA, has been selected for the position of President and Chief Executive Officer at Ajinomoto Althea, Inc., a fully integrated, contract development and manufacturing organization located in San Diego, California.

Mr. Enloe is a dynamic business leader with 20+ years of biotechnology executive management experience. His background includes broad skill sets in leadership, financial management, manufacturing and contractual negotiations within both small startups and multi-national corporations.

Mr. Enloe joins Ajinomoto Althea, Inc., after serving most recently as Head of the Viral Therapeutics Business Unit at Lonza AG. In 2009, Mr. Enloe formed Vivante GMP Solutions, Inc., and was later responsible for executing the sale of the company to Lonza AG. This union formed a new business unit which he has managed since 2010. Prior to this he was President and CEO of Introgen Technical Services, Inc., which later became the basis for Vivante.

Robin Toft, President and CEO of Sanford Rose Associates® – Toft Group said: “We are exceedingly proud to have recommended Mr. Enloe to Ajinomoto Althea Inc., and congratulate him on his new role as President and CEO. We believe he will make an outstanding contribution to the continued development of the company’s business. We look forward to the continued success of both Mr. Enloe and our client, Ajinomoto Althea Inc.”

“I am thrilled about the growth strategy Ajinomoto Althea Inc. is pursuing, and am very excited to lead the company as President and Chief Executive Officer,” said Mr. Enloe. “All of my past experiences to date have positioned me for this incredible role. Althea’s vision for the future is bright and I’m confident that together, we will achieve great success.”

Ajinomoto Althea Inc., (www.altheatech.com) is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Ajinomoto Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Ajinomoto Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Ajinomoto Althea’s formulation technology platform includes Crystalomics?, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Ajinomoto Althea also has an innovative and proven recombinant protein expression technology called Corynex?.

Sanford Rose Associates® - Toft Group (www.sanfordrose.net/toftgroup) is committed to filling mid to executive-level management positions exclusively in biotechnology, medical device, diagnostic, pharmaceutical and healthcare companies. Sanford Rose Associates® - Toft Group is the top performing Life Sciences focused executive search firm within the global Sanford Rose Associates® network, which has 50 offices worldwide and is a member of the International Executive Search Federation (IESF). We can help bring “A-players” to your organization- please contact us below:

Robin Toft, President and CEO, Sanford Rose Associates – Toft Group at (858) 546-4801 robin@sanfordrose.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES